Form 8-K - Current report:
SEC Accession No. 0001213900-25-023789
Filing Date
2025-03-14
Accepted
2025-03-13 17:58:21
Documents
15
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0234181-8k_rafael.htm   iXBRL 8-K 32272
2 PRESS RELEASE, DATED MARCH 13, 2025, REPORTING THE RESULTS OF OPERATIONS FOR THE ea023418101ex99-1_rafael.htm EX-99.1 78367
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8874
  Complete submission text file 0001213900-25-023789.txt   304783

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250313.xsd EX-101.SCH 3036
5 XBRL LABEL FILE rfl-20250313_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rfl-20250313_pre.xml EX-101.PRE 22374
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0234181-8k_rafael_htm.xml XML 3557
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 25737099
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)